Nasdaq
GALT
Galectin Therapeutics Inc.
- Health Care
- 1 day
- +4.2%
- 1 month
- −30.2%
- 1 year
- −14.6%
$3.22 · Mkt cap $325M
At the 6 Aug 2026 close
Nasdaq
Galectin Therapeutics Inc.
$3.22 · Mkt cap $325M
At the 6 Aug 2026 close
Galectin Therapeutics Inc. trades under the ticker GALT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $325M. The last closing price was $3.22, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −14.6%, and −30.2% over the past month. Returns are price returns and exclude dividends.
This page exists because GALT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.